Research and Development

Showing 15 posts of 9607 posts found.

Roche and PTC sign CNS research deal

September 4, 2009 Research and Development CNS, Roche

 PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …

Head-to-head boost for Brilinta over Plavix

September 4, 2009 Research and Development, Sales and Marketing AZ, Brillinta

 AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …

Roche’s MabThera expands licence in leukaemia

September 4, 2009 Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

Merck launches Saflutan in first European markets

September 4, 2009 Research and Development, Sales and Marketing Merck, ophthalmology

Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …

Novartis swine-flu jab effective in single dose

September 3, 2009 Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

Pharmafocus expands into Europe

September 3, 2009 Research and Development, Sales and Marketing Europe

 The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …

Merck unveils post-merger leadership team

September 3, 2009 Research and Development, Sales and Marketing MA, Merck

The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …

New cancer cases set to hit 17 million by 2020

September 2, 2009 Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

Shire goes for early approval in Gaucher disease

September 1, 2009 Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

Pradaxa data boosts Boehringer

September 1, 2009 Research and Development, Sales and Marketing Boehringer, Pradaxa

Boehringer Ingelheim has unveiled new positive data for its blood-thinner Pradaxa, showing it reduces the risk of stroke compared to …

Pfizer agrees price cut in Clinton deal

September 1, 2009 Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Indian government accepts pro-patent report

September 1, 2009 Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …

Basilea buoyed by sales increase

September 1, 2009 Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

Supply chain controls blamed for UK medicines shortage

August 27, 2009 Manufacturing and Production, Research and Development supply chain

Industry supply chain controls in the UK have overwhelmingly made medicines more difficult to source and have put patients risk, …
The Gateway to Local Adoption Series

Latest content